Well, OPC, I'm not sure what you do (did) for a living, but my guess is you are more able/qualified to discern if people are lying, than if reolysin can be approved. So, if you're right about the lying (and I'm not saying your wrong, but only that I mildly disagree with you), then it seems that management like that will at least try to screw shareholders, if they can do so to their own benefit. Even if the science is right and the FDA will agree with you, we shareholders can still lose. That's a heck of an extra risk to take on a business that is fraught with risk and unforeseen potholes.

As long as you're going to laugh at my "trust management," I'll have to share with you that I laughed at your scheme for financing, so thank you for that! Your position on appealing the turn down, you may well be right there, I can't dispute that position any farther than I already have.